Use of recombinant hirudin in patients with heparin-induced thrombocytopenia with thrombosis requiring cardiopulmonary bypass. [electronic resource]
Producer: 20000313Description: 263-6 p. digitalISSN:- 0003-3022
- Anticoagulants -- adverse effects
- Cardiopulmonary Bypass
- Fatal Outcome
- Heart Valve Prosthesis Implantation
- Heparin -- adverse effects
- Hirudin Therapy
- Hirudins -- analogs & derivatives
- Humans
- Intraoperative Period
- Male
- Middle Aged
- Mitral Valve
- Multiple Organ Failure
- Partial Thromboplastin Time
- Postoperative Complications
- Recombinant Proteins -- therapeutic use
- Thrombocytopenia -- chemically induced
- Thrombosis -- chemically induced
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.